Sign in
  1. Home
  2. Companies
  3. The Estée Lauder Companies
  4. Financial Ratios
The Estée Lauder Companies logo
The Estée Lauder Companies EL
$ 103.86 2.97%
report update icon

Quarterly report 2026-Q4
added 08-19-2026

The Estée Lauder Companies Financial Ratios 2026-2008 | EL

Brief overview of The Estée Lauder Companies 's multiples and efficiency

The comparison uses the five latest available annual observations between 2020 and 2024.

Key multiples at the end of the period are P/E 81.5x (median 55.52x), EV/EBITDA 32.9x (median 21.76x), P/S 2.29x (median 3.52x). The combined multiple level is about 17% below the company's historical norm, suggesting more cautious expectations.

The 1/P/E calculation produces a 1.2% earnings yield. It does not capture future growth or capital structure.

Returns on assets and capital are represented by ROE -29.3%, ROA -5.7%, ROCE -5.4%. Losses and negative capital returns make ordinary P/E-like references unstable or inapplicable.

The PEG ratio is 6.41x; investors pay a high price per unit of expected growth.

The cash cycle changed only slightly and ended at 105.7 days.

Conclusion

The Estée Lauder Companies trades below its own history, but weak profitability may explain the discount. Low multiples alone do not prove undervaluation.

Annual Financial Ratios The Estée Lauder Companies

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

P/E

 195.1 -28.9 81.5 55.5 40.8 39.2 121.2 38.5 44.5 29.1 30.8 31.2 23.8 24.9 24.4 29.5 33.3 13.2 -

P/S

 2.4 2.3 2.1 3.5 5.5 7.0 5.9 4.6 3.6 3.1 3.1 3.2 2.6 2.5 2.2 2.3 - - -

EPS

 0.5 -3.1 1.1 2.8 6.6 7.9 1.9 4.9 3.0 3.4 3.0 2.9 3.1 2.6 2.2 1.8 0.9 1.3 -

EV (Enterprise Value)

 32 B 29.8 B 29.9 B 52.1 B 94.3 B 108 B 79.4 B 74.5 B 55 B 42.4 B 39.1 B 37.5 B 31.1 B 27.8 B 23.4 B 23 B 10.3 B 2.51 B -402 M

EBITDA per Share

 4.35 0.12 5 6.3 10.8 9.01 3.37 8.74 7.65 6.49 5.83 5.31 5.72 4.89 4.34 3.66 1.98 3.33 -

EV/EBITDA

 20.3 678.1 16.7 23.1 24.2 32.9 26.0 21.8 18.0 16.2 16.5 17.2 12.9 13.3 12.4 14.3 13.2 3.8 -

PEG

 0.29 -5.27 6.41 2.82 1.29 1.31 -72.92 0.61 -3.88 2.25 6.32 -3.89 1.28 1.28 1.03 0.63 - - -

P/B

 1.8 1.6 1.5 2.4 4.7 5.1 4.7 15.6 10.5 8.3 9.6 9.3 7.4 7.7 7.6 7.8 2.1 0.7 -

P/CF

 20.0 25.8 14.1 32.4 32.3 31.0 37.0 38.7 25.4 28.0 27.2 23.1 28.0 33.2 29.6 30.6 12.0 4.8 -

ROE %

 4.78 -29.31 7.70 18.08 43.08 47.20 17.57 40.47 23.52 28.37 31.07 29.80 31.12 30.89 31.19 26.48 17.65 15.40 -

ROA %

 0.92 -5.70 1.89 4.31 11.52 13.09 3.91 13.57 8.82 10.80 12.08 13.22 15.30 14.27 13.00 11.17 6.45 4.95 -

ROCE %

 5.76 -5.43 6.07 9.23 22.24 16.55 4.81 30.63 24.66 21.93 26.65 26.32 31.39 29.92 31.18 26.49 13.82 24.01 -

Current Ratio

 - - - - - - - 1.6 1.9 1.8 1.6 2.1 2.3 2.2 1.8 1.9 - - -

DSO

 37.0 41.5 37.2 35.3 34.3 32.6 38.6 45.0 39.7 43.1 40.8 39.8 45.9 42.0 39.8 39.2 - - -

DIO

 201.6 207.9 212.6 235.9 230.0 217.4 209.0 216.2 207.7 221.5 211.4 211.3 218.8 200.7 179.9 187.6 82.5 - -

DPO

 152.2 143.7 128.3 139.6 149.0 136.6 137.0 160.6 151.7 125.1 119.9 110.4 88.7 86.8 90.3 84.2 42.4 - -

Operating Cycle

 238.6 249.4 249.8 271.2 264.2 250.0 247.6 261.1 247.3 264.6 252.2 251.0 264.7 242.7 219.7 226.8 82.5 - -

Cash Conversion Cycle

 86.4 105.7 121.5 131.6 115.3 113.4 110.6 100.6 95.6 139.5 132.3 140.6 176.0 155.9 129.4 142.6 40.0 - -

All numbers in USD currency

Quarterly Financial Ratios The Estée Lauder Companies

2026-Q4 2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 2.7199999999999998 0.44 -1.64 -0.43 0.45 0.92 0.87 0.44 -1.64 -0.43 1.1 0.92 0.87 0.09 3.02 0.44 1.1 1.37 2.47 1.55 3.02 1.91 4.93 1.25 2.4 1.44 2.4 1.44 1.55 1.65 1.55 1.65 1.58 1.36 1.58 1.36 0.33 1.16 0.33 1.16 1.17 0.8 1.17 0.8 1.21 0.83 1.21 0.83 1.15 0.6 1.15 0.6 1.11 0.78 1.11 0.78 1.16 0.77 1.16 0.77 1.03 0.71 1.03 1.43

EBITDA per Share

 -1.56 K 0.94 -1.51 -0.24 1.65 1.58 1.7 0.94 -1.04 0.24 1.66 1.58 1.7 0.84 4.04 0.93 1.66 2.34 4.4 2.16 4.04 3.09 7.52 1.76 3 2.38 3.8 2.38 0.76 2.55 1.52 2.55 2.16 2.14 2.86 2.14 1.96 1.89 2.62 1.89 1.7 1.43 2.28 1.43 1.72 1.48 2.25 1.48 1.67 1.17 2.19 1.17 1.7 1.39 2.17 1.39 1.69 1.44 2.09 1.44 1.55 1.28 1.91 2.56

ROE %

 3.86 -10.51 -7.96 12.08 19.78 1.61 -7.67 -6.51 -4.33 15.49 19.23 29.58 26.39 27.44 35.65 34.11 40.74 51.45 53.93 67.53 65.83 64.57 65.00 23.79 16.08 12.08 13.42 28.74 41.55 42.68 40.89 41.28 36.56 25.95 23.62 24.88 23.74 32.33 31.34 28.75 29.37 30.49 31.31 32.87 32.92 31.93 29.11 31.60 29.66 29.43 31.76 27.93 27.84 31.05 32.59 31.60 30.93 31.65 33.01 32.70 32.67 11.26 1.56 4.74

ROA %

 1.96 -2.13 -1.40 3.01 4.59 0.78 -1.47 -1.24 -0.56 3.82 4.71 8.23 7.44 7.96 10.25 9.29 11.29 14.31 15.08 18.96 18.37 17.91 17.62 6.89 4.78 3.41 4.33 8.12 12.37 13.79 13.92 14.21 12.95 9.40 8.92 9.42 9.03 11.87 11.52 10.56 10.85 12.25 12.77 13.61 14.04 14.38 13.68 15.10 14.51 14.48 15.50 13.54 13.33 14.06 14.33 13.79 13.27 13.28 13.55 13.43 13.44 4.54 0.66 1.99

ROCE %

 5.86 0.07 1.35 8.87 11.76 5.03 0.94 0.75 1.93 9.49 10.87 16.97 15.83 16.12 20.25 19.28 22.08 27.35 28.66 35.03 34.04 32.39 31.70 25.24 26.95 21.44 23.28 17.89 21.42 28.09 28.17 33.45 31.38 30.43 29.44 29.23 28.68 30.10 30.12 31.43 31.33 32.52 33.80 34.69 35.72 36.29 34.78 35.36 33.92 34.35 36.41 38.12 40.77 42.23 43.68 45.71 47.89 48.97 49.73 48.91 48.05 10.36 13.84 9.97

Current Ratio

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 1.5 1.6 1.5 1.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

 29.8 39.3 34.9 43.3 36.5 40.0 37.5 43.7 40.9 46.5 32.6 41.8 39.0 45.9 29.1 46.7 40.4 43.9 20.5 46.1 35.8 41.2 15.6 43.4 35.6 38.5 22.4 43.8 44.6 48.3 36.1 44.9 48.0 47.9 41.2 43.1 42.6 44.5 34.0 40.5 44.5 45.9 35.8 42.5 43.1 43.7 34.3 41.4 43.5 50.0 41.3 50.0 46.4 46.7 35.4 46.1 48.8 47.7 33.0 43.7 46.0 42.8 31.5 -

DIO

 114.7 212.9 197.8 195.1 186.8 179.3 163.4 203.3 202.9 257.3 197.8 202.4 216.1 246.6 224.5 242.7 227.8 264.8 117.0 249.8 195.7 221.8 100.2 224.5 181.8 235.9 173.6 227.8 180.3 204.1 175.8 183.8 167.1 182.9 162.2 169.8 179.5 192.3 179.2 176.9 184.4 196.0 181.1 179.2 174.6 189.2 188.4 184.0 188.6 216.9 206.0 207.5 183.7 193.7 174.8 176.8 165.6 173.6 158.0 159.3 155.8 168.9 164.9 -

DPO

 82.8 153.7 142.7 135.6 123.9 118.7 104.9 120.5 108.1 137.9 107.3 100.9 99.2 131.3 124.7 119.2 108.5 143.3 67.0 142.7 116.5 137.1 67.7 145.3 104.3 130.2 99.1 128.0 96.8 128.7 130.6 124.9 95.7 116.1 118.5 106.4 85.9 97.2 101.2 93.2 83.3 96.7 102.7 95.3 80.7 90.9 98.4 89.3 80.5 88.5 83.5 86.5 74.9 79.1 75.6 69.4 61.6 77.5 72.3 67.0 67.0 74.4 74.0 -

Operating Cycle

 - - - - 214.1 - - 247.0 243.8 276.3 - 244.1 255.2 303.6 - 289.4 268.2 308.8 137.5 295.9 231.4 263.0 115.9 267.9 217.4 274.4 196.0 271.6 224.8 252.4 212.0 228.6 215.1 230.8 203.4 212.9 222.2 236.8 213.2 217.4 228.9 241.9 216.8 221.7 217.7 232.8 222.7 225.4 232.1 266.9 247.4 257.4 230.1 240.4 210.2 222.9 214.4 221.3 191.0 203.0 201.8 211.7 196.4 -

Cash Conversion Cycle

 - - - - 100.5 - - 126.6 135.7 161.7 - 143.2 155.9 185.2 - 170.2 159.7 165.4 70.5 153.2 114.9 125.9 48.2 122.6 113.1 144.2 97.0 143.7 128.1 123.7 81.4 103.8 119.4 114.7 84.9 106.5 136.3 139.7 112.0 124.2 145.6 145.2 114.1 126.5 137.0 141.9 124.2 136.1 151.6 178.4 163.9 170.9 155.2 161.3 134.6 153.5 152.8 143.8 118.7 136.1 134.8 137.3 122.4 -

All numbers in USD currency

Multiples are an important financial analysis tool for the company The Estée Lauder Companies , allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Household products industry

Issuer Price % 24h Market Cap Country
Natura &Co Holding S.A. Natura &Co Holding S.A.
NTCO
 		- - $ 9.02 B -
Unilever PLC Unilever PLC
UL
 		$ 64.2 0.15 % $ 140 B britainBritain
LifeVantage Corporation LifeVantage Corporation
LFVN
 		$ 6.25 2.38 % $ 78.3 M usaUSA
Acme United Corporation Acme United Corporation
ACU
 		$ 63.14 0.33 % $ 239 M usaUSA
Church & Dwight Co. Church & Dwight Co.
CHD
 		$ 98.55 0.05 % $ 23.9 B usaUSA
Colgate-Palmolive Company Colgate-Palmolive Company
CL
 		$ 88.77 0.23 % $ 71.8 B usaUSA
The Clorox Company The Clorox Company
CLX
 		$ 93.06 0.02 % $ 11.5 B usaUSA
Coty Coty
COTY
 		$ 2.93 0.17 % $ 2.57 B usaUSA
Dogness (International) Corporation Dogness (International) Corporation
DOGZ
 		$ 0.98 2.04 % $ 13.1 M chinaChina
e.l.f. Beauty e.l.f. Beauty
ELF
 		$ 109.67 2.1 % $ 6.39 B usaUSA
Edgewell Personal Care Company Edgewell Personal Care Company
EPC
 		$ 28.87 1.3 % $ 1.37 B usaUSA
Helen of Troy Limited Helen of Troy Limited
HELE
 		$ 28.4 0.78 % $ 653 M bermudaBermuda
Hims & Hers Health Hims & Hers Health
HIMS
 		$ 27.71 0.84 % $ 6.23 B usaUSA
Inter Parfums Inter Parfums
IPAR
 		$ 116.69 2.35 % $ 3.75 B usaUSA
Kimberly-Clark Corporation Kimberly-Clark Corporation
KMB
 		$ 104.96 0.05 % $ 34.8 B usaUSA
Mannatech, Incorporated Mannatech, Incorporated
MTEX
 		$ 9.0 23.46 % $ 17.1 M usaUSA
Nature's Sunshine Products Nature's Sunshine Products
NATR
 		$ 14.02 1.59 % $ 252 M usaUSA
Nu Skin Enterprises Nu Skin Enterprises
NUS
 		$ 4.84 2.98 % $ 239 M usaUSA
Newell Brands Newell Brands
NWL
 		$ 6.11 0.66 % $ 2.56 B usaUSA
The Procter & Gamble Company The Procter & Gamble Company
PG
 		$ 146.44 0.02 % $ 342 B usaUSA
Revlon Revlon
REV
 		- -4.41 % $ 212 M usaUSA
Spectrum Brands Holdings Spectrum Brands Holdings
SPB
 		$ 88.5 0.08 % $ 2.27 B usaUSA
United-Guardian United-Guardian
UG
 		$ 7.14 0.92 % $ 32.8 M usaUSA
USANA Health Sciences USANA Health Sciences
USNA
 		$ 14.96 3.67 % $ 277 M usaUSA